玻璃体内注射阿柏西普后未治疗的对侧眼糖尿病性黄斑水肿的减轻
Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept.
作者信息
Calvo Charles M, Sridhar Jayanth, Shahlaee Abtin, Ho Allen C
出版信息
Ophthalmic Surg Lasers Imaging Retina. 2016 May 1;47(5):474-6. doi: 10.3928/23258160-20160419-12.
A 59-year-old patient with bilateral worsening diabetic macular edema received intravitreal injection of aflibercept (Eylea; Regeneron, Tarrytown, NY) to the left eye only. On 1-month follow-up, there was noted bilateral improvement of visual acuity and diabetic macular edema on spectral-domain optical coherence tomography imaging, reflecting bilateral effect of unilateral treatment with aflibercept. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:474-476.].
一名59岁双侧糖尿病性黄斑水肿病情加重的患者仅接受了阿柏西普（阿瓦斯汀；再生元公司，纽约州塔里敦）玻璃体内注射至左眼。在1个月的随访中，光谱域光学相干断层扫描成像显示双侧视力和糖尿病性黄斑水肿均有改善，这反映了阿柏西普单侧治疗的双侧效应。[《眼科手术、激光与视网膜成像》。2016年；47:474 - 476。]
Zotero 插件